Better-Than-Expected Results, Innovation Grants, and Offering Enhancements - Research Report on Thermo Fisher, Covance, LabCorp, Life Technologies, and Agilent

NEW YORK, November 1, 2013 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting Thermo Fisher Scientific Inc. (NYSE: TMO), Covance Inc. (NYSE: CVD), Laboratory Corporation of America Holdings (NYSE: LH), Life Technologies Corporation (NASDAQ: LIFE), and Agilent Technologies, Inc. (NYSE: A). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Thermo Fisher Scientific Inc. Research Report

On October 23, 2013, Thermo Fisher Scientific Inc. (Thermo Fisher) reported Q3 FY 2013 financial results (period ended September 28, 2013). In Q3 FY 2013, the Company's revenues increased 3.4% YoY to $3.2 billion. Q3 FY 2013 net income was $317.6 million, or $0.86 per diluted share, compared with $290.4 million, or $0.79 per diluted share, in Q3 FY 2012. "We executed well in a challenging market environment, driving productivity and leveraging our PPI Business System to deliver solid adjusted operating margin expansion," said Marc N. Casper, President and CEO of Thermo Fisher. "On the technology front, we had great uptake of our mass spectrometry systems launched at ASMS from customers in both life sciences and applied markets. In the quarter, we introduced new technologies to improve bioprocessing quality and efficiency as well as a new portable analyzer for on-site inspection of animal feed." The Full Research Report on Thermo Fisher Scientific Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/45ed_TMO]

--

Covance Inc. Research Report

On October 29, 2013, Covance Inc. (Covance) reported Q3 2013 financial results. In Q3 2013, the Company reported net revenue of $606.7 million, up 11.4% YoY. Q3 2013 net income was $44.2 million, or $0.78 per share, compared with $37.8 million, or $0.69 per share, in Q3 2012. "Our better-than-expected results in the third quarter were driven by exceptional performance in our central laboratory and continued strong results in clinical development," said Joe Herring, Chairman and CEO of Covance. Herring added, "Looking ahead to the fourth quarter of 2013, we expect sequential growth in revenue and operating income in both our Early and Late-Stage development segments, despite increased spending on our strategic IT programs." The Full Research Report on Covance Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/5691_CVD]

--

Laboratory Corporation of America Holdings Research Report

On October 29, 2013, Laboratory Corporation of America Holdings (LabCorp) announced that it has priced its offering of $700 million in senior notes. The Company informed that the offering has two tranches - $400 million aggregate principal amount of 2.50% Senior Notes due 2018 and $300 million aggregate principal amount of 4.00% Senior Notes due 2023 - both of which will bear interest from November 1, 2013. The Company expects the closing of the offering to be on November 1, 2013, payable semi-annually on November 1 and May 1, commencing on May 1, 2014. LabCorp plans to use the net proceeds of the offering for repayment of all or a portion of the outstanding borrowings under its existing credit facility dated December 21, 2011, as well as for general corporate purposes. The Full Research Report on Laboratory Corporation of America Holdings - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/c267_LH]

--

Life Technologies Corporation Research Report

On October 24, 2013, Life Technologies Corporation (Life Technologies) announced that it has awarded Innovation Grants to five research projects in the Digital PCR Applications Grant Program, during the American Society for Human Genetics (ASHG) conference in Boston. The Company informed that each of the Innovation Grant recipients will receive a QuantStudio 3D Digital PCR System for research projects that demonstrated innovative applications in digital PCR. The Full Research Report on Life Technologies Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/d5de_LIFE]

--

Agilent Technologies, Inc. Research Report

On October 29, 2013, Agilent Technologies, Inc. (Agilent) announced new software options for the T4010S LTE RF and T4020S LTE RRM test systems. The Company informed that the new capabilities will provide coverage for LTE-Advanced Carrier Aggregation test cases. "We are very excited to further extend our strong position in wireless test by adding LTE-Advanced capabilities to our test systems," said Joe DePond, Vice President and General Manager of Mobile Broadband Operation at Agilent. "Carrier aggregation represents the immediate future of LTE-Advanced cellular deployments. Our T4000S systems can now deliver cutting-edge conformance and R&D test solutions for this important technology." The Full Research Report on Agilent Technologies, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/075e_A]

----

EDITOR NOTES:

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
5. For any urgent concerns or inquiries, please contact us at [email protected].
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

AnalystsCorner.com

SOURCE Analysts' Corner